All News

Although I was aware of lymphedema, it wasn't really something on my radar screen, until I heard those words.

When you lose six months of your life to battling cancer, you make every moment going forward count.

The combination use of Cyramza (ramucirumab) plus docetaxel showed improvements in objective response rate (ORR) and a positive trend in overall survival (OS) among patients with advanced bladder cancer, according to additional results from the phase 3 RANGE trial.

Age should not limit which patients with metastatic melanoma receive immunotherapy.

Sometimes every little bump or bruise can make me feel terrified of what it might be. Understanding how my brain is wired helps me to fight being overcome with the fear of recurrence.

Don't end up alone lying in the hospital surround by the smells of disinfectant.

Breast cancer survivor with the recently discovered PALB2 genetic mutation talks about what self-care might look like before, during and after her preventative double mastectomy.

So, what was the first thing I thought about when I vowed to not think about cancer? Cancer, of course.

Researchers evaluates microsatellite instability-high status, tumor mutation burden and high PD-L1 expression to determine which grade of tumors would benefit from immunotherapy treatment among women with endometrioid endometrial cancer.

The Food and Drug Administration (FDA) approved a next-generation sequencing (NGS) companion diagnostic assay that can detect BRCA1/2 genetic mutations, as well as the percentage of genomic loss of heterozygosity (LOH) in patients with ovarian cancer.

Our dance with cancer is tenuous, so we better lead the way.

Albeit growing popularity of at-home genetic testing, it is still necessary to seek professional medical opinions from genetic counselors to help discuss results.

One breast cancer survivor's thoughts on news from a recent study about the potential risks of surgery.

Six and 12 months after finishing chemo, I reflected on how my healing continued.

When cancer becomes a topic of conversation during a job interview.

Advice from a long time survivor proves fruitful in helping this breast cancer survivor regroup.

Cancer decisions get to be made based on each person's unique situation.

This cancer survivor shares his experience with advancements in cancer treatment.

In particular, patients whose tumors have certain genetic mutations may respond especially well to this combination approach.

As a testicular cancer survivor, April is a step in the right direction, but we can do more

There are a number of different treatment options for patients with relapsed myeloma, and it is important that patients and providers dicuss health history to determine which one is best.

It is OK to laugh during cancer treatment. Laughing and humor are one of the few things cancer can't touch.

I learned a lot during my time as a caregiver, and plan to carry that over in my career as an oncology nurse.

We have lots of questions. And often the answers we seek are as close as the people we meet.

Being unsure of medical coverage can cause cancer patients undue stress, which is very unhealthy.

For patients with melanoma, administration of a PD-1 checkpoint blockade therapy in the neoadjuvant setting – meaning it was given before the main treatment – could result in improved outcomes and better insight to patient responses.

Thinking back on my friends who fought cancer with me can sometimes be daunting, but I like to look for the silver lining.

The Food and Drug Administration (FDA) approved Tagrisso as a first-line treatment for patients with non–small cell lung cancer (NSCLC) whose tumors harbor EGFR mutations.